日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
World / US and Canada

Chinese biopharmaceutical company debuts on Nasdaq

By HENG WEILI in New York (China Daily USA) Updated: 2016-03-18 10:01

Hutchison ChinaMediTech Ltd, a Hong Kong-based biopharmaceutical company, started trading on Thursday on the Nasdaq Stock Market in New York.

Chi-Med, as the company is also known, tradeson Nasdaq under the symbol HCM. Shares closed at $13.40 on Thursday, 10 cents below their initial public offering price, after reaching an intraday high of $14.68.

In the IPO, which priced on Thursday morning, Chi-Med sold 7.5 million American depositary shares, raising $101.25 million. Bank of America, Merrill Lynch and Deutsche Bank Securities were the lead underwriters.

The company, which is majority owned by the multinational conglomerate CK Hutchison Holdings Ltd,calls itself a "globally-focused healthcare group which researches, develops, manufactures and sells pharmaceuticals and health-related consumer products".

Its innovation platform is focused on discovering and developing therapeutics in oncology and autoimmune diseases. The commercial platform manufactures, markets and distributes prescription drugs and consumer health products in China.

More specifically, Chi-Med is a developer of targeted, small molecule kinase (enzyme) inhibitors to treat a range of solid tumors, blood cancers and immune diseases. The company is conducting 20 active clinical trials in various countries, including two late-stage studies with AstraZeneca in the US and Eli Lilly in China, working toward potential new drug applications.

"Today is an important milestone for Chi-Med as we go public in the US market," said Simon To, executive director and chairman, who along with CEO Christian Hoggrang the Nasdaq closing bell on Thursday.

"Our R&D is focused on addressing the shortcomings of many of the currently approved kinase inhibitors, specifically the off-target toxicities that limit drug exposure and efficacy," To said. "We hope our efforts will result in life-saving therapies for the many patients around the world with few or no treatment options."

"We welcome Chi-Med as they continue to advance their rapidly growing pipeline," said Bob McCooey, who is the senior vice-president for listing services at Nasdaq. "As the venue of choice for innovators and visionaries around the globe, we are excited to be the strategic partner that supports revolutionary companies as they take on the world stage."

hengweili@chinadailyusa.com

Trudeau visits Sina Weibo
May gets little gasp as EU extends deadline for sufficient progress in Brexit talks
Ethiopian FM urges strengthened Ethiopia-China ties
Yemen's ex-president Saleh, relatives killed by Houthis
Most Popular
Hot Topics

...
主站蜘蛛池模板: 一区二区黄色片 | 亚洲视频精品 | 亚洲人精品 | 久久天天躁狠狠躁夜夜av | 在线中文字幕播放 | 亚洲最大中文字幕 | 国产成人精品影院 | 国产黄色成人 | 夜夜嗨av一区二区三区网页 | 97久草| 日韩专区一区 | 中文在线中文资源 | 二三区视频 | 亚洲三级在线视频 | 午夜看片网| 97久久综合 | 久久新视频| 国产91精品久久久久久久 | 国产精品2018 | 色999视频| 国产超碰在线观看 | 免费久久久 | 牛人盗摄一区二区三区视频 | 欧美日韩一二 | 蜜桃av免费观看 | 不卡的日韩av | 日本www黄 | 四虎在线观看视频 | 黄页免费在线观看 | 久久激情影院 | 欧美激情视频在线播放 | 日韩成人免费在线 | 欧美天天射| 亚洲乱亚洲乱 | 黄色片在线免费观看视频 | 亚洲第一视频网站 | 久久久综合久久久 | 欧美日韩精品国产 | 长河落日电视连续剧免费观看01 | 亚洲免费视频网 | 成人日韩在线 |